229 related articles for article (PubMed ID: 23563092)
1. The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancer.
Kuo HY; Chen YC; Chang HY; Jeng JC; Lin EH; Pan CM; Chang YW; Wang ML; Chou YT; Shih HM; Wu CW
Carcinogenesis; 2013 Aug; 34(8):1708-16. PubMed ID: 23563092
[TBL] [Abstract][Full Text] [Related]
2. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
3. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
4. PML positively regulates interferon gamma signaling.
El Bougrini J; Dianoux L; Chelbi-Alix MK
Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
6. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
7. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
8. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.
Kim YE; Ahn JH
PLoS Pathog; 2015 Mar; 11(3):e1004785. PubMed ID: 25812002
[TBL] [Abstract][Full Text] [Related]
9. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
[TBL] [Abstract][Full Text] [Related]
10. TIP30 nuclear translocation negatively regulates EGF-dependent cyclin D1 transcription in human lung adenocarcinoma.
Shuai S; Yan X; Zhang J; Kang S; Chen F; Luo R; Li A
Cancer Lett; 2014 Nov; 354(1):200-9. PubMed ID: 25135222
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
12. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter.
Vallian S; Chin KV; Chang KS
Mol Cell Biol; 1998 Dec; 18(12):7147-56. PubMed ID: 9819401
[TBL] [Abstract][Full Text] [Related]
13. Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.
Maroui MA; Pampin M; Chelbi-Alix MK
J Virol; 2011 Dec; 85(24):13164-73. PubMed ID: 21994459
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
Kobayashi S; Shimamura T; Monti S; Steidl U; Hetherington CJ; Lowell AM; Golub T; Meyerson M; Tenen DG; Shapiro GI; Halmos B
Cancer Res; 2006 Dec; 66(23):11389-98. PubMed ID: 17145885
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy.
Chung YL; Tsai TY
Mol Cancer Res; 2009 Oct; 7(10):1672-85. PubMed ID: 19808906
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
17. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
[TBL] [Abstract][Full Text] [Related]
18. PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.
Klanrit P; Taebunpakul P; Flinterman MB; Odell EW; Riaz MA; Melino G; Salomoni P; Mymryk JS; Gäken J; Farzaneh F; Tavassoli M
Oncogene; 2009 Oct; 28(39):3499-512. PubMed ID: 19597475
[TBL] [Abstract][Full Text] [Related]
19. CK2 and PML: regulating the regulator.
Lallemand-Breitenbach V; de Thé H
Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
[TBL] [Abstract][Full Text] [Related]
20. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
